Ardent Health, Inc.
For the period ended Nov 4, 2026. Filed Nov 4, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Nov 4, 2026 · Filed Nov 4, 2026
Use the contents to explore the available documents and sections.
Contents
EX-99.1 · Operating Statistics
Operating Statistics
(Unaudited)
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||
|---|---|---|---|---|---|---|
| 2026 | % Change | 2025 | 2026 | % Change | 2025 | |
| Total revenue (in thousands) | $1,624,856 | 3.1% | $1,576,746 | $4,848,971 | 2.7% | $4,719,260 |
| Hospitals operated (at period end) (1) | 30 | 0.0% | 30 | 30 | 0.0% | 30 |
| Licensed beds (at period end) (2) | 4,281 | 0.0% | 4,281 | 4,281 | 0.0% | 4,281 |
| Utilization of licensed beds (3) | 49% | 0.0% | 49% | 50% | 0.0% | 50% |
| Admissions (4) | 41,899 | 0.1% | 41,862 | 123,935 | (0.7)% | 124,786 |
| Adjusted admissions (5) | 91,933 | 2.9% | 89,328 | 267,503 | 2.5% | 261,031 |
| Inpatient surgeries (6) | 9,250 | (5.0)% | 9,732 | 27,612 | (4.2)% | 28,822 |
| Outpatient surgeries (7) | 22,684 | (0.6)% | 22,813 | 67,419 | 0.1% | 67,385 |
| Total surgeries | 31,934 | (1.9)% | 32,545 | 95,031 | (1.2)% | 96,207 |
| Emergency room visits (8) | 163,909 | 1.7% | 161,198 | 476,973 | (0.4)% | 479,069 |
| Patient days (9) | 193,773 | 0.1% | 193,558 | 580,125 | (0.8)% | 584,510 |
| Total encounters (10) | 1,627,839 | 3.2% | 1,577,281 | 4,773,160 | 5.6% | 4,519,815 |
| Average length of stay (11) | 4.62 | 0.0% | 4.62 | 4.68 | 0.0% | 4.68 |
| Net patient service revenue per adjusted admission (12) | $17,370 | 0.7% | $17,252 | $17,857 | 0.6% | $17,745 |
(1)Hospitals operated (at period end). This metric represents the total number of hospitals operated by us at the end of the applicable period, irrespective of
whether the hospital real estate is (i) owned by us, (ii) leased by us or (iii) held through a controlling interest in a JV. This metric includes the managed
clinical operations of the hospital at UT Health North Campus in Tyler, Texas ("UT Health North Campus Tyler"), a hospital owned by The University of
Texas Health Science Center at Tyler, an affiliate of The University of Texas System. Since we only manage the clinical operations of UT Health North
Campus Tyler, the financial results of such entity are not consolidated under Ardent Health, Inc.
(2)Licensed beds (at period end). This metric represents the total number of beds for which the appropriate state agency licenses a facility, regardless of
whether the beds are actually available for patient use.
(3)Utilization of licensed beds. This metric represents a measure of the actual utilization of our inpatient facilities, computed by (i) dividing patient days by
the number of days in each period, and (ii) further dividing that number by average licensed beds, which is calculated by dividing total licensed beds (at
period end) by the number of days in the period, multiplied by the number of days in the period the licensed beds were in existence.
(4)Admissions. This metric represents the number of patients admitted for inpatient treatment during the applicable period.
(5)Adjusted admissions. This metric is used by management as a general measure of combined inpatient and outpatient volume. Adjusted admissions
provides management with a key performance indicator that considers both inpatient and outpatient volumes by applying an inpatient volume measure
(admissions) to a ratio of gross inpatient and outpatient revenue to gross inpatient revenue. Gross inpatient and outpatient revenue reflect gross inpatient
and outpatient charges prior to estimated contractual adjustments, uninsured discounts, implicit price concessions, and other discounts. The calculation of
adjusted admissions is summarized as follows:
| Adjusted Admissions | = | Admissions | x | (Gross Inpatient Revenue + Gross Outpatient Revenue) |
|---|---|---|---|---|
| Gross Inpatient Revenue | ||||
(6)Inpatient surgeries. This metric represents the number of surgeries performed on patients who have been admitted to our hospitals. Pain management, c-
sections, and certain diagnostic procedures are excluded from inpatient surgeries.
(7)Outpatient surgeries. This metric represents the number of surgeries performed on patients who have not been admitted to our hospitals. Pain
management, c-sections, and certain diagnostic procedures are excluded from outpatient surgeries.
(8)Emergency room visits. This metric represents the total number of patients provided with emergency room treatment during the applicable period.
(9)Patient days. This metric represents the total number of days of care provided to patients admitted to our hospitals during the applicable period.
(10)Total encounters. This metric represents the total number of events where healthcare services are rendered resulting in a billable event during the
applicable period. This includes both hospital and ambulatory patient interactions.
(11)Average length of stay. This metric represents the average number of days admitted patients stay in our hospitals.
(12)Net patient service revenue per adjusted admission. This metric represents net patient service revenue divided by adjusted admissions for the applicable
period. Net patient service revenue reflects gross inpatient and outpatient charges less estimated contractual adjustments, uninsured discounts, implicit
price concessions, and other discounts.
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Net income | $63,387 | $1,207 | $156,564 | $155,873 |
| Adjusted EBITDA Addbacks: | ||||
| Income tax expense (benefit) | 17,638 | (3,410) | 42,255 | 38,114 |
| Interest expense | 15,317 | 13,914 | 40,097 | 42,819 |
| Depreciation and amortization | 41,059 | 39,156 | 125,387 | 114,666 |
| Noncontrolling interest earnings | (18,871) | (24,685) | (55,299) | (65,018) |
| Loss on extinguishment and modification of debt | — | 7,344 | — | 7,344 |
| Other non-operating losses (1) | — | 353 | — | 1,130 |
| Cybersecurity Incident recoveries, net (2) | (1,000) | (2,950) | (1,000) | (22,655) |
| Certain legal matters and related costs | — | — | 2,464 | — |
| Enterprise restructuring costs (3) | 5,360 | 2,846 | 32,160 | 6,043 |
| Exit and acquisition-related costs (4) | 1,614 | 1,122 | 4,071 | 3,486 |
| Enterprise resource planning system conversion costs (5) | 5,913 | 692 | 11,651 | 1,319 |
| Equity-based compensation | 7,313 | 9,674 | 24,194 | 30,183 |
| Loss (income) from disposed operations | 17 | (11) | (5,860) | 22 |
| Adjusted EBITDA | $137,747 | $45,252 | $376,684 | $313,326 |
| Total revenue | $1,624,856 | $1,576,746 | $4,848,971 | $4,719,260 |
| Adjusted EBITDA margin | 8.5% | 2.9% | 7.8% | 6.6% |
(1)Other non-operating losses include losses realized on certain non-recurring events or events that are non-operational in nature.
(2)Cybersecurity Incident recoveries, net primarily represent gains on insurance recovery proceeds associated with the Cybersecurity Incident, net of
incremental information technology and litigation costs. During thethree and nine months ended September 30, 2026, the Company recognized a gain of
$1.0 million associated with the release of an accrual for expected litigation-related related costs.
(3)Enterprise restructuring costs represent expenses related to employee termination benefits of$0.2 million and$2.8 million for the three months ended
September 30, 2026 and 2025, respectively, and$21.5 million and$6.0 million for thenine months ended September 30, 2026 and 2025, respectively, for
position eliminations and executive leadership departures as part of strategic organizational changes, and third-party professional fees and expenses for
advisory services related to enterprise restructuring activities of$5.2 million and$10.7 million for thethree and nine months ended September 30, 2026,
respectively. Employee termination benefit costs reflect severance and related employee benefit expenses associated with a discrete enterprise restructuring
program designed to streamline and improve the Company's organizational structure.
(4)Exit and acquisition-related costs represent penalties and costs incurred for terminating pre-existing contracts at acquired facilities of$0.8 million and$0.2
million for the three months ended September 30, 2026 and 2025, respectively, and$0.9 million and$0.5 million for thenine months ended September 30,
2026 and 2025, respectively, third-party professional fees and expenses incurred in connection with potential and completed acquisitions of$0.6 million for
the three months ended September 30, 2026, and$2.6 million and$0.8 million for thenine months ended September 30, 2026 and 2025, respectively, and
system integration costs for completed acquisitions of$0.2 million and$0.9 million for the three months ended September 30, 2026 and 2025, respectively,
and$0.6 million and$2.2 million for thenine months ended September 30, 2026 and 2025, respectively.
(5)Enterprise resource planning system conversion costs represent various costs incurred related to a single system conversion project to implement a new
project of$5.2 million and$0.6 million for the three months ended September 30, 2026 and 2025, respectively, and$10.7 million and$1.2 million for the
nine months ended September 30, 2026 and 2025, respectively, and contract labor expense directly related to the conversion project of$0.8 million and$0.1
million for the three months ended September 30, 2026 and 2025, respectively, and$1.0 million and$0.1 million for thenine months ended September 30,
2026 and 2025, respectively. These costs do not include post-implementation licensing, maintenance and operating costs associated with the new enterprise
resource planning system.
| Three Months Ended September 30, 2026 | Nine Months Ended September 30, 2026 | |
|---|---|---|
| Net income | $63,387 | $156,564 |
| Adjusted EBITDAR Addbacks: | ||
| Income tax expense | 17,638 | 42,255 |
| Interest expense | 15,317 | 40,097 |
| Depreciation and amortization | 41,059 | 125,387 |
| Noncontrolling interest earnings | (18,871) | (55,299) |
| Cybersecurity Incident recoveries, net (1) | (1,000) | (1,000) |
| Certain legal matters and related costs | — | 2,464 |
| Enterprise restructuring costs (2) | 5,360 | 32,160 |
| Exit and acquisition-related costs (3) | 1,614 | 4,071 |
| Enterprise resource planning system conversion costs (4) | 5,913 | 11,651 |
| Equity-based compensation | 7,313 | 24,194 |
| Loss (income) from disposed operations | 17 | (5,860) |
| Rent expense payable to REITs (5) | 41,875 | 125,010 |
| Adjusted EBITDAR | $179,622 | $501,694 |
(1)Cybersecurity Incident recoveries, net primarily represent gains on insurance recovery proceeds associated with the Cybersecurity Incident, net of
incremental information technology and litigation costs. During thethree and nine months ended September 30, 2026, the Company recognized a gain of
$1.0 million associated with the release of an accrual for expected litigation-related related costs.
(2)Enterprise restructuring costs represent expenses related to employee termination benefits of$0.2 million and$21.5 million for thethree and nine months
ended September 30, 2026, respectively, for position eliminations and executive leadership departures as part of strategic organizational changes, and third-
party professional fees and expenses for advisory services related to enterprise restructuring activities of$5.2 million and$10.7 million for thethree and nine
months ended September 30, 2026, respectively. Employee termination benefit costs reflect severance and related employee benefit expenses associated
with a discrete enterprise restructuring program designed to streamline and improve the Company's organizational structure.
(3)Exit and acquisition-related costs represent penalties and costs incurred for terminating pre-existing contracts at acquired facilities of$0.8 million and$0.9
million for thethree and nine months ended September 30, 2026, respectively, third-party professional fees and expenses incurred in connection with
potential and completed acquisitions of$0.6 million and$2.6 million for thethree and nine months ended September 30, 2026, respectively, and system
integration costs for completed acquisitions of$0.2 million and$0.6 million for thethree and nine months ended September 30, 2026, respectively.
(4)Enterprise resource planning system conversion costs represent various costs incurred related to a single system conversion project to implement a new
project of$5.2 million and$10.7 million for thethree and nine months ended September 30, 2026, respectively, and contract labor expense directly related
to the conversion project of$0.8 million and$1.0 million for thethree and nine months ended September 30, 2026, respectively. These costs do not include
post-implementation licensing, maintenance and operating costs associated with the new enterprise resource planning system.
(5)Rent expense payable to REITs for thethree and nine months ended September 30, 2026 consists of rent expense of$39.0 million and$116.4 million,
respectively, related to the Ventas Master Lease and other lease agreements with Ventas for medical office buildings and rent expense of$2.9 million and
$8.6 million, respectively, related to a lease arrangement with MPT for the lease of Hackensack Meridian Mountainside Medical Center.
(Unaudited; in millions)
| Guidance for the Full Year Ending December 31, 2026 | ||||
|---|---|---|---|---|
| Previous Guidance | Revised Guidance | |||
| Low | High | Low | High | |
| Net income | $202 | $260 | $209 | $254 |
| Adjusted EBITDA Addbacks: | ||||
| Income tax expense | 53 | 69 | 56 | 69 |
| Interest expense | 56 | 53 | 56 | 54 |
| Depreciation and amortization | 175 | 170 | 171 | 167 |
| Noncontrolling interest earnings | (92) | (97) | (77) | (87) |
| Cybersecurity Incident recoveries, net (1) | (7) | (7) | (7) | (7) |
| Certain legal matters and related costs | 3 | 3 | 3 | 3 |
| Enterprise restructuring costs (2) | 37 | 32 | 37 | 36 |
| Exit and acquisition-related costs (3) | 5 | 4 | 6 | 5 |
| Enterprise resource planning system conversion costs (4) | 17 | 16 | 17 | 16 |
| Equity-based compensation | 42 | 38 | 35 | 31 |
| Income from disposed operations | (6) | (6) | (6) | (6) |
| Adjusted EBITDA | $485 | $535 | $500 | $535 |
(1)Cybersecurity Incident recoveries, net primarily represent gains on insurance recovery proceeds associated with the Cybersecurity Incident, net of
incremental information technology and litigation costs.
(2)Enterprise restructuring costs represent expenses related to employee termination benefits for position eliminations and executive leadership departures as
part of strategic organizational changes and third-party professional fees and expenses for advisory services related to enterprise restructuring activities.
These costs reflect severance and related employee benefit expenses associated with a discrete enterprise restructuring program designed to streamline and
improve the Company’s organizational structure.
(3)Exit and acquisition-related costs represent penalties and costs incurred for terminating pre-existing contracts at acquired facilities, third-party professional
fees and expenses incurred in connection with potential and completed acquisitions, and system integration costs for completed acquisitions.
(4)Enterprise resource planning system conversion costs represent various costs incurred related to a single system conversion project to implement a new
project and contract labor expense directly related to the conversion project. These costs do not include post-implementation licensing, maintenance and
operating costs associated with the new enterprise resource planning system.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.